NR Therapeutics' Incubator/Accelerator Round

NR Therapeutics raised a round of funding on , . Investors include Dartmouth Regional Technology Center.

Brenner and his laboratory are the inventors of means of assaying and utilizing nicotinamide riboside, a naturally occurring compound that appears to critically important in anti-aging (longevity) and…

Articles about NR Therapeutics' Incubator/Accelerator Round: